EURINE-ACT - EURINE-ACT is an international prospective study that examines the diagnostic and prognostic value of urine steroidobolomics in patients with adrenocortical tumours.
ADIUVO - The ADIUVO study is a prospective, randomized, open-label, controlled, international, phase III trial for patients with ACC after radical resection.
FIRM-ACT (First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment) Recruitment closed October 2009, first results will be expected end of 2010.
PMT3 - is an international multicenter prospective study of biomarkers for prediction of malignancy and hereditary pheochromocytoma and paragliomas (PPGLs).